2020
DOI: 10.1111/jvp.12855
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and clinical effects of xylazine and dexmedetomidine in horses recovering from isoflurane anesthesia

Abstract: This study determined the pharmacokinetics and compared the clinical effects of xylazine and dexmedetomidine in horses recovering from isoflurane anesthesia. Six healthy horses aged 8.5 ± 3 years and weighing 462 ± 50 kg were anesthetized with isoflurane for 2 hr under standard conditions on two occasions one‐week apart. In recovery, horses received 200 μg/kg xylazine or 0.875 μg/kg dexmedetomidine intravenously and were allowed to recover without assistance. These doses were selected because they have been us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(16 citation statements)
references
References 24 publications
1
15
0
Order By: Relevance
“…In horses, all alpha-2 adrenergic agonists available for administration to horses have been used for balanced anaesthesia due to their sedation and potent analgesic effects [ 22 ]. Although not currently registered for horses in countries such as Europe, Australia and the United States, medetomidine, including its active enantiomer dexmedetomidine, have been shown to be short-acting, have high clearance rates and undergo rapid distribution, compared to other alpha-2 agonists such as xylazine, making them more suitable for intravenous infusions [ 23 , 24 , 25 , 26 , 27 ]. This is in addition to producing similar post-anaesthetic recovery times and recovery qualities in horses as compared to xylazine [ 24 , 27 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In horses, all alpha-2 adrenergic agonists available for administration to horses have been used for balanced anaesthesia due to their sedation and potent analgesic effects [ 22 ]. Although not currently registered for horses in countries such as Europe, Australia and the United States, medetomidine, including its active enantiomer dexmedetomidine, have been shown to be short-acting, have high clearance rates and undergo rapid distribution, compared to other alpha-2 agonists such as xylazine, making them more suitable for intravenous infusions [ 23 , 24 , 25 , 26 , 27 ]. This is in addition to producing similar post-anaesthetic recovery times and recovery qualities in horses as compared to xylazine [ 24 , 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although not currently registered for horses in countries such as Europe, Australia and the United States, medetomidine, including its active enantiomer dexmedetomidine, have been shown to be short-acting, have high clearance rates and undergo rapid distribution, compared to other alpha-2 agonists such as xylazine, making them more suitable for intravenous infusions [ 23 , 24 , 25 , 26 , 27 ]. This is in addition to producing similar post-anaesthetic recovery times and recovery qualities in horses as compared to xylazine [ 24 , 27 ]. These pharmacokinetic properties of medetomidine led to its choice as both a premedication and co-infusion agent in this study.…”
Section: Discussionmentioning
confidence: 99%
“…Eighteen publications fell into this category [299][300][301][302][303][304][305][306][307][308][309][310][311][312][313][314][315][316]. Most of the studies were published after the year 2000 and the main inhalant agent used was isoflurane, followed by sevoflurane.…”
Section: Drugs Before/during Recoverymentioning
confidence: 99%
“…Sedation with alpha2-adrenergic agonists improves the recovery quality [302][303][304], an effect that seems to be dose-dependent [302,311]. There is no clear evidence which alpha2-adrenergic agonist is the best [307,314,315]. However, Bienert et al, (2003) and Woodhouse et al, (2013) showed a benefit of romifidine over xylazine [304,309].…”
Section: Drugs Before/during Recoverymentioning
confidence: 99%
See 1 more Smart Citation